Compare SID & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SID | MRVI |
|---|---|---|
| Founded | 1941 | 2014 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2002 | 2020 |
| Metric | SID | MRVI |
|---|---|---|
| Price | $0.89 | $5.80 |
| Analyst Decision | Strong Sell | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $1.40 | ★ $4.13 |
| AVG Volume (30 Days) | ★ 4.4M | 2.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $185,743,000.00 |
| Revenue This Year | $1.71 | $12.54 |
| Revenue Next Year | $1.58 | $7.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.84 | $2.29 |
| 52 Week High | $2.20 | $7.44 |
| Indicator | SID | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 37.56 | 36.84 |
| Support Level | $0.88 | $5.67 |
| Resistance Level | $1.06 | $6.55 |
| Average True Range (ATR) | 0.06 | 0.34 |
| MACD | -0.01 | -0.15 |
| Stochastic Oscillator | 18.91 | 24.84 |
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations port concessions and fleets of road transport vehicles. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.